FTC OKs $76M Astellas-Maxygen Protein Program Deal

By Joseph Marks · March 29, 2011, 2:01 PM EDT

The Federal Trade Commission granted an early termination on Monday to the 30-day waiting period before Astellas Pharma Inc. can complete its $76 million purchase of all of Maxygen Inc.'s equity...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Joseph

March 31, 2011
Judge Nixes Dismissal Bid In Thalomid Antitrust Suit
March 30, 2011
Sonova Execs Resign Amid Insider Trading Probe
March 28, 2011
Class Rep Pushes To Kill Deal Over Chemo Drug Sales
March 21, 2011
Tenn. Passes Law To Skirt Health Care Mandate
March 18, 2011
US Sues Teva Over Generic HIV Drug
March 14, 2011
Guatemalans Infected With Syphilis Want US To Pay
March 11, 2011
Minn. Pharmacy Class Suit Wrongly Remanded: 8th Circ.
March 09, 2011
Tort Reform Group Sees Conflict In Cuomo Panel
March 09, 2011
State AGs Support Health Care Law At 4th Circ.
March 02, 2011
Shareholder Seeks To Halt $1.2B Clinical Data Sale